Table 7 Simple linear regression model of factors predicting difference in WBC count pre-vax vs. post-vax 2 in IO + CT-treated group
Characteristic | Difference between WBC count pre-vax vs. post-vax 2 in the IO + CT group | |||
|---|---|---|---|---|
N | Beta | 95% CI | p-value | |
Gender | 37 | 0.299 | ||
Female | — | — | ||
Male | 0.80 | -0.74, 2.3 | ||
Age | 37 | 0.03 | -0.04, 0.11 | 0.381 |
BMI | 37 | -0.05 | -0.21, 0.12 | 0.552 |
Concomitant disease | 37 | 0.867 | ||
No | — | — | ||
Yes | 0.15 | -1.6, 1.9 | ||
Cardiovascular disease | 37 | 0.385 | ||
No | — | — | ||
Yes | 0.60 | -0.79, 2.0 | ||
Metabolic disease | 37 | 0.937 | ||
No | — | — | ||
Yes | 0.07 | -1.6, 1.8 | ||
Hematologic disease | 37 | 0.573 | ||
No | — | — | ||
Yes | 1.2 | -3.1, 5.5 | ||
Immune-mediated | 37 | 0.839 | ||
No | — | — | ||
Yes | 0.31 | -2.8, 3.4 | ||
Lung disease | 37 | 0.130 | ||
No | — | — | ||
Yes | -3.2 | -7.3, 1.0 | ||
Liver disease | 37 | 0.553 | ||
No | — | — | ||
Yes | 0.90 | -2.2, 4.0 | ||
Allergy to drugs | 37 | 0.835 | ||
No | — | — | ||
Yes | -0.17 | -1.8, 1.4 | ||
Endocrine disease | 37 | 0.258 | ||
No | — | — | ||
Yes | 1.1 | -0.86, 3.1 | ||
Advanced disease | 37 | 0.737 | ||
No | — | — | ||
Yes | -0.37 | -2.6, 1.9 | ||
Antibody before vaccine | 31 | 0.706 | ||
Negative | — | — | ||
Positive | 0.51 | -2.2, 3.3 | ||
Antibody Titer one-month | 25 | 0.553 | ||
Negative | — | — | ||
Positive | 0.73 | -1.8, 3.3 | ||
Antibody Titer at 3-months | 22 | 0.988 | ||
Negative | — | — | ||
Positive | -0.02 | -2.8, 2.7 | ||
Antibody Titer at 6-months | 9 | 0.515 | ||
Negative | — | — | ||
Positive | 1.1 | -2.7, 5.0 | ||
Growth factor use | 37 | 0.193 | ||
No | — | — | ||
Yes | 2.7 | -1.4, 6.9 | ||